CASE DISCUSSION
AIRH Dialogues with the Change Makers in Healthcare AI - Dr. Dwarikanath Mahapatra
Presented by Dr. Dwarikananth MahapatraViews
41
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Artificial Intelligence is rapidly transforming healthcare by enhancing diagnostic accuracy, enabling personalized treatment strategies, and supporting data-driven clinical decision-making. In this AIRH Dialogue, Dr. Dwarikanath Mahapatra explores how AI is reshaping modern medicine across multiple...
Case Summary
- Clinicians increasingly face proposals for medical imaging and broader healthcare artificial intelligence intended to support diagnosis and workflow. A framework for trustworthy AI was emphasized around three practical questions: whether the system works for patients in real clinical settings, whether clinicians know when to trust or not trust its outputs, and what occurs when the system fails or produces unexpected results.
Speaker Profile
Dr. Dwarikananth Mahapatra
AI Scientist & Consultant, Prof. Khalifa University, Abu Dhabi Emirate, United Arab EmiratesDr. Dwarikanath Mahapatra is an AI Scientist and Consultant at Khalifa University, specializing in the application of artificial intelligence to advance healthcare and biomedical research. With extensive expertise in medical image analysis, machine learning, deep learning, and AI-driven clinical decision support, he has contributed to the development of innovative solutions that enhance diagnostic accuracy and patient outcomes. Passionate about translating cutting-edge AI research into real-world clinical practice, Dr. Mahapatra actively collaborates with clinicians and researchers to drive the future of precision medicine and longevity-focused healthcare.
Disclosures
<span style="color: #000000;font-family: Poppins, sans-serif;background-color: #f6f6f6">Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.</span>